Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial
Six-month ATT is non-inferior to 9-month ATT for treating tubercular posterior uveitis, though it may vary between the different clinical phenotypes.
Authors
- Soumyava Basu (ORCID: https://orcid.org/0000-0002-6513-8786)
- May Zun Aung Win (ORCID: https://orcid.org/0000-0002-2687-2283)
- Somsiri Sukavatcharin
- Md Hasnat Ali
- Anup Kelgaonkar (ORCID: https://orcid.org/0000-0002-3983-4200)
- Talluri Ronnie Abhishek
Institutions
- Dr. Reddy's Laboratories (United States) (US)
- Mahidol University (TH)
- University of Medicine Magway (MM)
- L V Prasad Eye Institute (IN)
Publication Details
- Journal
- Seminars in Ophthalmology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1080/08820538.2025.2599224
- Citations
- 1
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.71